Form 4 for TXG 10x Genomics, Inc.
Accepted 2026-08-17 16:08:49 ET · period of report 2026-08-13 · accession 0001610717-26-000359 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-08-17 16:08 | 2026-08-13+ | TXG | Teichmann Sarah A. | Dir | S - Sale | $57.25 | -7,551 | 28.1K | -21% | -$432.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-08-13 | S | D | 5,278 | $57.29 | 30,331 | D | — | — | (F1) The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 14, 2026. |
| 2 | Common | Class A Common Stock | 2026-08-14 | S | D | 2,273 | $57.15 | 28,058 | D | — | — | (F1) The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 14, 2026. |